| 1 | separate | 4,411 |
| 2 | successive | 873 |
| 3 | 5-mm | 145 |
| 4 | 10-mm | 110 |
| 5 | 1-mm | 92 |
| 6 | 3-mm | 68 |
| 7 | 4-mm | 65 |
| 8 | temperature-controlled | 64 |
| 9 | rescue-free | 30 |
| 10 | 3-ml | 28 |
| 11 | equal-sized | 22 |
| 12 | moderate-sized | 22 |
| 13 | fe-s | 18 |
| 14 | climate-controlled | 17 |
| 15 | 7-mm | 16 |
| 16 | 20-mm | 13 |
| 17 | day-shift | 13 |
| 18 | season-specific | 11 |
| 19 | 90-degree | 10 |
| 20 | even-numbered | 10 |
| 21 | 25-mm | 9 |
| 22 | 0.6-mm | 8 |
| 23 | 1-mm-thick | 8 |
| 24 | nonvisualized | 8 |
| 25 | single-sex | 8 |
| 26 | thirty-minute | 8 |
| 27 | triennial | 8 |
| 28 | 10-mm-long | 7 |
| 29 | 50-patient | 7 |
| 30 | four-wave | 7 |
| 31 | patients.the | 7 |
| 32 | preoperatory | 7 |
| 33 | fast-response | 6 |
| 34 | intron-containing | 6 |
| 35 | larger-sized | 6 |
| 36 | 1.2-mm | 5 |
| 37 | 13-h | 5 |
| 38 | controlled-environment | 5 |
| 39 | fewer-than-four | 5 |
| 40 | growsafe | 5 |
| 41 | previously-published | 5 |
| 42 | production-scale | 5 |
| 43 | sanjiu | 5 |
| 44 | 100-kcal | 4 |
| 45 | 2,450-mhz | 4 |
| 46 | 2.7-mm | 4 |
| 47 | consumer-based | 4 |
| 48 | positive-to-negative | 4 |
| 49 | soundproof | 4 |
| 50 | venepunctures | 4 |
| 51 | 1.9-mm | 3 |
| 52 | 10-repetition | 3 |
| 53 | 2.8-mm | 3 |
| 54 | 24-mm | 3 |
| 55 | 80-m | 3 |
| 56 | best/worst | 3 |
| 57 | cu4i4 | 3 |
| 58 | ehr-enabled | 3 |
| 59 | end-submaximal | 3 |
| 60 | floor-pen | 3 |
| 61 | gorges | 3 |
| 62 | intermediate-quality | 3 |
| 63 | mbc-resistant | 3 |
| 64 | months.no | 3 |
| 65 | mutation-free | 3 |
| 66 | post-needling | 3 |
| 67 | stimulus-locked | 3 |
| 68 | surface-specific | 3 |
| 69 | voxel-level | 3 |
| 70 | wasp-dependent | 3 |
| 71 | 13-mm | 2 |
| 72 | 15-l | 2 |
| 73 | 200-meter | 2 |
| 74 | 3.7-mm | 2 |
| 75 | 30-patient | 2 |
| 76 | 300-g | 2 |
| 77 | 4.7-mm | 2 |
| 78 | 7,24 | 2 |
| 79 | algorithm-defined | 2 |
| 80 | art-strategy | 2 |
| 81 | climatic-controlled | 2 |
| 82 | cluster-hole | 2 |
| 83 | co2-fixing | 2 |
| 84 | congruency-level | 2 |
| 85 | contralateral-central | 2 |
| 86 | cytodiagnostic | 2 |
| 87 | denv3 | 2 |
| 88 | device-observers | 2 |
| 89 | early-onset/comorbidity | 2 |
| 90 | face-sharing | 2 |
| 91 | festive | 2 |
| 92 | fungal-inoculated | 2 |
| 93 | gel-use | 2 |
| 94 | high-enrolling | 2 |
| 95 | intervention/outcome | 2 |
| 96 | levitated | 2 |
| 97 | long-haul | 2 |
| 98 | multi-diode | 2 |
| 99 | multi-tracer | 2 |
| 100 | multidiode | 2 |
| 101 | nck-binding | 2 |
| 102 | non-equidistant | 2 |
| 103 | non-hot | 2 |
| 104 | non-triggered | 2 |
| 105 | nonheating | 2 |
| 106 | nonsuspend | 2 |
| 107 | nrtis+one | 2 |
| 108 | patients/7 | 2 |
| 109 | pedometer-recorded | 2 |
| 110 | postintravenous | 2 |
| 111 | pre-cimt | 2 |
| 112 | real-size | 2 |
| 113 | ruptured/unruptured | 2 |
| 114 | slice-encoding | 2 |
| 115 | sovrapubic | 2 |
| 116 | stent-era | 2 |
| 117 | teacher-supervised | 2 |
| 118 | wire-top | 2 |
| 119 | +1033 | 1 |
| 120 | +2030 | 1 |
| 121 | +2456 | 1 |
| 122 | -10.3mm | 1 |
| 123 | -11.4mm | 1 |
| 124 | -12.4-mm | 1 |
| 125 | -5.7-mm | 1 |
| 126 | -637 | 1 |
| 127 | -6±109 | 1 |
| 128 | 0.2-g | 1 |
| 129 | 0.2-g/dl | 1 |
| 130 | 0.32-mm | 1 |
| 131 | 0.4+/-18.4mm | 1 |
| 132 | 0.72-mm | 1 |
| 133 | 1,10-phenanthroline-chelated | 1 |
| 134 | 1-oz | 1 |
| 135 | 1.4-mm | 1 |
| 136 | 10.1mm | 1 |
| 137 | 109mm | 1 |
| 138 | 1123.1 | 1 |
| 139 | 123.73mm | 1 |
| 140 | 125-g | 1 |
| 141 | 126.7mm | 1 |
| 142 | 13,089 | 1 |
| 143 | 130-min | 1 |
| 144 | 131,747 | 1 |
| 145 | 137.4mm | 1 |
| 146 | 13:14-atom | 1 |
| 147 | 146/88mm | 1 |
| 148 | 147/87mm | 1 |
| 149 | 15,332 | 1 |
| 150 | 15,930 | 1 |
| 151 | 1500x | 1 |
| 152 | 151/90mm | 1 |
| 153 | 159mm | 1 |
| 154 | 169-mm | 1 |
| 155 | 179-mm | 1 |
| 156 | 18-d | 1 |
| 157 | 18-floor | 1 |
| 158 | 19,282 | 1 |
| 159 | 1905±37 | 1 |
| 160 | 1926±0 | 1 |
| 161 | 199mm | 1 |
| 162 | 1∼5 | 1 |
| 163 | 2,338 | 1 |
| 164 | 2-k | 1 |
| 165 | 20/10-mm | 1 |
| 166 | 2117.6 | 1 |
| 167 | 26,670 | 1 |
| 168 | 28-kb | 1 |
| 169 | 3-dimension-perspective | 1 |
| 170 | 36-hour-long | 1 |
| 171 | 398,237 | 1 |
| 172 | 4.4-mm | 1 |
| 173 | 4471+/-2315 | 1 |
| 174 | 45cm-drop | 1 |
| 175 | 5.6+/-17.7mm | 1 |
| 176 | 5.6-mm | 1 |
| 177 | 51,525 | 1 |
| 178 | 51,791 | 1 |
| 179 | 589±640 | 1 |
| 180 | 5rm-10rm | 1 |
| 181 | 6-ounce | 1 |
| 182 | 616,607 | 1 |
| 183 | 631-775 | 1 |
| 184 | 64,474 | 1 |
| 185 | 640-756 | 1 |
| 186 | 7.0-mm | 1 |
| 187 | 7.9-min | 1 |
| 188 | 7.9-mm | 1 |
| 189 | 79.52mm | 1 |
| 190 | 7×7 | 1 |
| 191 | 8.0±5.1mm | 1 |
| 192 | 9.6±3.6mm | 1 |
| 193 | 9792 | 1 |
| 194 | aaq+amx | 1 |
| 195 | albuterol-free | 1 |
| 196 | alliqots | 1 |
| 197 | almnau7 | 1 |
| 198 | alncr | 1 |
| 199 | another.subgroup | 1 |
| 200 | as-aerobic | 1 |
| 201 | australian-grown | 1 |
| 202 | biobrick | 1 |
| 203 | biotansform | 1 |
| 204 | body-similar | 1 |
| 205 | c-qids | 1 |
| 206 | carbohydrate-salt | 1 |
| 207 | cirs-066 | 1 |
| 208 | cis-fluorine | 1 |
| 209 | clinically-interpretable | 1 |
| 210 | closed-chain | 1 |
| 211 | co-investigational | 1 |
| 212 | conc2h | 1 |
| 213 | content-distinct | 1 |
| 214 | convex-shaped | 1 |
| 215 | coxib-nsaid | 1 |
| 216 | dna-supported | 1 |
| 217 | drug-dependency | 1 |
| 218 | dsr/placebo | 1 |
| 219 | empirically-defined | 1 |
| 220 | extreme-high-temperature | 1 |
| 221 | fe-x6 | 1 |
| 222 | fibrin/semisynthetic | 1 |
| 223 | film-type | 1 |
| 224 | flavonoid-glycosylating | 1 |
| 225 | flexiforce | 1 |
| 226 | foot-detection | 1 |
| 227 | granny | 1 |
| 228 | grpaca-based | 1 |
| 229 | guidewire-induced | 1 |
| 230 | homogeneic | 1 |
| 231 | host/metal | 1 |
| 232 | hours/each | 1 |
| 233 | image-detection | 1 |
| 234 | imp-15-producing | 1 |
| 235 | intrasaccadic | 1 |
| 236 | iso-echoic | 1 |
| 237 | kaolinite-based | 1 |
| 238 | levels-the | 1 |
| 239 | lignocellulosic-based | 1 |
| 240 | lip-specific | 1 |
| 241 | lowest-frequency | 1 |
| 242 | lrrct | 1 |
| 243 | m=4721 | 1 |
| 244 | mean=1.12 | 1 |
| 245 | meta-analyses/network | 1 |
| 246 | mg8 | 1 |
| 247 | micro-ecd | 1 |
| 248 | mid-urethra | 1 |
| 249 | mix-effect | 1 |
| 250 | mnaun+1 | 1 |
| 251 | mock-restaurant | 1 |
| 252 | moderate.two | 1 |
| 253 | months.multi-level | 1 |
| 254 | multirebound | 1 |
| 255 | near-native | 1 |
| 256 | ni13 | 1 |
| 257 | nmesintra-vaginal | 1 |
| 258 | non-meal | 1 |
| 259 | non-rainy | 1 |
| 260 | nonfilling | 1 |
| 261 | nonindustry-sponsored | 1 |
| 262 | o-capped | 1 |
| 263 | one-hour-treatment | 1 |
| 264 | opposite-oriented | 1 |
| 265 | par-frying | 1 |
| 266 | pcna-binding | 1 |
| 267 | phamarcology | 1 |
| 268 | phosphoserine/phosphothreonine-binding | 1 |
| 269 | pool-boiling | 1 |
| 270 | poorly-performing | 1 |
| 271 | post-screen | 1 |
| 272 | pre-pecified | 1 |
| 273 | predictive-learning | 1 |
| 274 | prenucleation | 1 |
| 275 | pseudoischemic | 1 |
| 276 | pt13 | 1 |
| 277 | purine-pyrimidine | 1 |
| 278 | quick-response | 1 |
| 279 | raised-floor | 1 |
| 280 | regular-set | 1 |
| 281 | relative-benefit | 1 |
| 282 | risk/severity | 1 |
| 283 | saliva-sparing | 1 |
| 284 | screenhouse | 1 |
| 285 | sections-an | 1 |
| 286 | sets×8-12 | 1 |
| 287 | shoebox | 1 |
| 288 | sirt3-targeted | 1 |
| 289 | skin-check | 1 |
| 290 | smaller-scale | 1 |
| 291 | solid-sided | 1 |
| 292 | st12 | 1 |
| 293 | stereodifferentiating | 1 |
| 294 | stoloniferous | 1 |
| 295 | stranguries | 1 |
| 296 | straw-enriched | 1 |
| 297 | structured-group | 1 |
| 298 | successeful | 1 |
| 299 | techniques.in | 1 |
| 300 | temperature-interval-specific | 1 |
| 301 | tetrahydropyridoimidazole-type | 1 |
| 302 | therapeutic-preventive | 1 |
| 303 | thermocol | 1 |
| 304 | thermopar | 1 |
| 305 | time-place | 1 |
| 306 | tippee | 1 |
| 307 | tissue-wiping | 1 |
| 308 | tm-derived | 1 |
| 309 | treatments-three | 1 |
| 310 | tuesday-friday | 1 |
| 311 | typesof | 1 |
| 312 | udma-based | 1 |
| 313 | venous-line | 1 |
| 314 | was.43 | 1 |
| 315 | weeks-a | 1 |
| 316 | xe-vacancy | 1 |
| 317 | μ2-phenoxo | 1 |
| 318 | ∼5-10 | 1 |
| 1 | +1033 | 1 |
| 2 | +2030 | 1 |
| 3 | +2456 | 1 |
| 4 | -10.3mm | 1 |
| 5 | -11.4mm | 1 |
| 6 | -12.4-mm | 1 |
| 7 | -5.7-mm | 1 |
| 8 | -637 | 1 |
| 9 | -6±109 | 1 |
| 10 | 0.2-g | 1 |
| 11 | 0.2-g/dl | 1 |
| 12 | 0.32-mm | 1 |
| 13 | 0.4+/-18.4mm | 1 |
| 14 | 0.6-mm | 8 |
| 15 | 0.72-mm | 1 |
| 16 | 1,10-phenanthroline-chelated | 1 |
| 17 | 1-mm | 92 |
| 18 | 1-mm-thick | 8 |
| 19 | 1-oz | 1 |
| 20 | 1.2-mm | 5 |
| 21 | 1.4-mm | 1 |
| 22 | 1.9-mm | 3 |
| 23 | 10-mm | 110 |
| 24 | 10-mm-long | 7 |
| 25 | 10-repetition | 3 |
| 26 | 10.1mm | 1 |
| 27 | 100-kcal | 4 |
| 28 | 109mm | 1 |
| 29 | 1123.1 | 1 |
| 30 | 123.73mm | 1 |
| 31 | 125-g | 1 |
| 32 | 126.7mm | 1 |
| 33 | 13,089 | 1 |
| 34 | 13-h | 5 |
| 35 | 13-mm | 2 |
| 36 | 130-min | 1 |
| 37 | 131,747 | 1 |
| 38 | 137.4mm | 1 |
| 39 | 13:14-atom | 1 |
| 40 | 146/88mm | 1 |
| 41 | 147/87mm | 1 |
| 42 | 15,332 | 1 |
| 43 | 15,930 | 1 |
| 44 | 15-l | 2 |
| 45 | 1500x | 1 |
| 46 | 151/90mm | 1 |
| 47 | 159mm | 1 |
| 48 | 169-mm | 1 |
| 49 | 179-mm | 1 |
| 50 | 18-d | 1 |
| 51 | 18-floor | 1 |
| 52 | 19,282 | 1 |
| 53 | 1905±37 | 1 |
| 54 | 1926±0 | 1 |
| 55 | 199mm | 1 |
| 56 | 1∼5 | 1 |
| 57 | 2,338 | 1 |
| 58 | 2,450-mhz | 4 |
| 59 | 2-k | 1 |
| 60 | 2.7-mm | 4 |
| 61 | 2.8-mm | 3 |
| 62 | 20-mm | 13 |
| 63 | 20/10-mm | 1 |
| 64 | 200-meter | 2 |
| 65 | 2117.6 | 1 |
| 66 | 24-mm | 3 |
| 67 | 25-mm | 9 |
| 68 | 26,670 | 1 |
| 69 | 28-kb | 1 |
| 70 | 3-dimension-perspective | 1 |
| 71 | 3-ml | 28 |
| 72 | 3-mm | 68 |
| 73 | 3.7-mm | 2 |
| 74 | 30-patient | 2 |
| 75 | 300-g | 2 |
| 76 | 36-hour-long | 1 |
| 77 | 398,237 | 1 |
| 78 | 4-mm | 65 |
| 79 | 4.4-mm | 1 |
| 80 | 4.7-mm | 2 |
| 81 | 4471+/-2315 | 1 |
| 82 | 45cm-drop | 1 |
| 83 | 5-mm | 145 |
| 84 | 5.6+/-17.7mm | 1 |
| 85 | 5.6-mm | 1 |
| 86 | 50-patient | 7 |
| 87 | 51,525 | 1 |
| 88 | 51,791 | 1 |
| 89 | 589±640 | 1 |
| 90 | 5rm-10rm | 1 |
| 91 | 6-ounce | 1 |
| 92 | 616,607 | 1 |
| 93 | 631-775 | 1 |
| 94 | 64,474 | 1 |
| 95 | 640-756 | 1 |
| 96 | 7,24 | 2 |
| 97 | 7-mm | 16 |
| 98 | 7.0-mm | 1 |
| 99 | 7.9-min | 1 |
| 100 | 7.9-mm | 1 |
| 101 | 79.52mm | 1 |
| 102 | 7×7 | 1 |
| 103 | 8.0±5.1mm | 1 |
| 104 | 80-m | 3 |
| 105 | 9.6±3.6mm | 1 |
| 106 | 90-degree | 10 |
| 107 | 9792 | 1 |
| 108 | aaq+amx | 1 |
| 109 | albuterol-free | 1 |
| 110 | algorithm-defined | 2 |
| 111 | alliqots | 1 |
| 112 | almnau7 | 1 |
| 113 | alncr | 1 |
| 114 | another.subgroup | 1 |
| 115 | art-strategy | 2 |
| 116 | as-aerobic | 1 |
| 117 | australian-grown | 1 |
| 118 | best/worst | 3 |
| 119 | biobrick | 1 |
| 120 | biotansform | 1 |
| 121 | body-similar | 1 |
| 122 | c-qids | 1 |
| 123 | carbohydrate-salt | 1 |
| 124 | cirs-066 | 1 |
| 125 | cis-fluorine | 1 |
| 126 | climate-controlled | 17 |
| 127 | climatic-controlled | 2 |
| 128 | clinically-interpretable | 1 |
| 129 | closed-chain | 1 |
| 130 | cluster-hole | 2 |
| 131 | co-investigational | 1 |
| 132 | co2-fixing | 2 |
| 133 | conc2h | 1 |
| 134 | congruency-level | 2 |
| 135 | consumer-based | 4 |
| 136 | content-distinct | 1 |
| 137 | contralateral-central | 2 |
| 138 | controlled-environment | 5 |
| 139 | convex-shaped | 1 |
| 140 | coxib-nsaid | 1 |
| 141 | cu4i4 | 3 |
| 142 | cytodiagnostic | 2 |
| 143 | day-shift | 13 |
| 144 | denv3 | 2 |
| 145 | device-observers | 2 |
| 146 | dna-supported | 1 |
| 147 | drug-dependency | 1 |
| 148 | dsr/placebo | 1 |
| 149 | early-onset/comorbidity | 2 |
| 150 | ehr-enabled | 3 |
| 151 | empirically-defined | 1 |
| 152 | end-submaximal | 3 |
| 153 | equal-sized | 22 |
| 154 | even-numbered | 10 |
| 155 | extreme-high-temperature | 1 |
| 156 | face-sharing | 2 |
| 157 | fast-response | 6 |
| 158 | fe-s | 18 |
| 159 | fe-x6 | 1 |
| 160 | festive | 2 |
| 161 | fewer-than-four | 5 |
| 162 | fibrin/semisynthetic | 1 |
| 163 | film-type | 1 |
| 164 | flavonoid-glycosylating | 1 |
| 165 | flexiforce | 1 |
| 166 | floor-pen | 3 |
| 167 | foot-detection | 1 |
| 168 | four-wave | 7 |
| 169 | fungal-inoculated | 2 |
| 170 | gel-use | 2 |
| 171 | gorges | 3 |
| 172 | granny | 1 |
| 173 | growsafe | 5 |
| 174 | grpaca-based | 1 |
| 175 | guidewire-induced | 1 |
| 176 | high-enrolling | 2 |
| 177 | homogeneic | 1 |
| 178 | host/metal | 1 |
| 179 | hours/each | 1 |
| 180 | image-detection | 1 |
| 181 | imp-15-producing | 1 |
| 182 | intermediate-quality | 3 |
| 183 | intervention/outcome | 2 |
| 184 | intrasaccadic | 1 |
| 185 | intron-containing | 6 |
| 186 | iso-echoic | 1 |
| 187 | kaolinite-based | 1 |
| 188 | larger-sized | 6 |
| 189 | levels-the | 1 |
| 190 | levitated | 2 |
| 191 | lignocellulosic-based | 1 |
| 192 | lip-specific | 1 |
| 193 | long-haul | 2 |
| 194 | lowest-frequency | 1 |
| 195 | lrrct | 1 |
| 196 | m=4721 | 1 |
| 197 | mbc-resistant | 3 |
| 198 | mean=1.12 | 1 |
| 199 | meta-analyses/network | 1 |
| 200 | mg8 | 1 |
| 201 | micro-ecd | 1 |
| 202 | mid-urethra | 1 |
| 203 | mix-effect | 1 |
| 204 | mnaun+1 | 1 |
| 205 | mock-restaurant | 1 |
| 206 | moderate-sized | 22 |
| 207 | moderate.two | 1 |
| 208 | months.multi-level | 1 |
| 209 | months.no | 3 |
| 210 | multi-diode | 2 |
| 211 | multi-tracer | 2 |
| 212 | multidiode | 2 |
| 213 | multirebound | 1 |
| 214 | mutation-free | 3 |
| 215 | nck-binding | 2 |
| 216 | near-native | 1 |
| 217 | ni13 | 1 |
| 218 | nmesintra-vaginal | 1 |
| 219 | non-equidistant | 2 |
| 220 | non-hot | 2 |
| 221 | non-meal | 1 |
| 222 | non-rainy | 1 |
| 223 | non-triggered | 2 |
| 224 | nonfilling | 1 |
| 225 | nonheating | 2 |
| 226 | nonindustry-sponsored | 1 |
| 227 | nonsuspend | 2 |
| 228 | nonvisualized | 8 |
| 229 | nrtis+one | 2 |
| 230 | o-capped | 1 |
| 231 | one-hour-treatment | 1 |
| 232 | opposite-oriented | 1 |
| 233 | par-frying | 1 |
| 234 | patients.the | 7 |
| 235 | patients/7 | 2 |
| 236 | pcna-binding | 1 |
| 237 | pedometer-recorded | 2 |
| 238 | phamarcology | 1 |
| 239 | phosphoserine/phosphothreonine-binding | 1 |
| 240 | pool-boiling | 1 |
| 241 | poorly-performing | 1 |
| 242 | positive-to-negative | 4 |
| 243 | post-needling | 3 |
| 244 | post-screen | 1 |
| 245 | postintravenous | 2 |
| 246 | pre-cimt | 2 |
| 247 | pre-pecified | 1 |
| 248 | predictive-learning | 1 |
| 249 | prenucleation | 1 |
| 250 | preoperatory | 7 |
| 251 | previously-published | 5 |
| 252 | production-scale | 5 |
| 253 | pseudoischemic | 1 |
| 254 | pt13 | 1 |
| 255 | purine-pyrimidine | 1 |
| 256 | quick-response | 1 |
| 257 | raised-floor | 1 |
| 258 | real-size | 2 |
| 259 | regular-set | 1 |
| 260 | relative-benefit | 1 |
| 261 | rescue-free | 30 |
| 262 | risk/severity | 1 |
| 263 | ruptured/unruptured | 2 |
| 264 | saliva-sparing | 1 |
| 265 | sanjiu | 5 |
| 266 | screenhouse | 1 |
| 267 | season-specific | 11 |
| 268 | sections-an | 1 |
| 269 | separate | 4,411 |
| 270 | sets×8-12 | 1 |
| 271 | shoebox | 1 |
| 272 | single-sex | 8 |
| 273 | sirt3-targeted | 1 |
| 274 | skin-check | 1 |
| 275 | slice-encoding | 2 |
| 276 | smaller-scale | 1 |
| 277 | solid-sided | 1 |
| 278 | soundproof | 4 |
| 279 | sovrapubic | 2 |
| 280 | st12 | 1 |
| 281 | stent-era | 2 |
| 282 | stereodifferentiating | 1 |
| 283 | stimulus-locked | 3 |
| 284 | stoloniferous | 1 |
| 285 | stranguries | 1 |
| 286 | straw-enriched | 1 |
| 287 | structured-group | 1 |
| 288 | successeful | 1 |
| 289 | successive | 873 |
| 290 | surface-specific | 3 |
| 291 | teacher-supervised | 2 |
| 292 | techniques.in | 1 |
| 293 | temperature-controlled | 64 |
| 294 | temperature-interval-specific | 1 |
| 295 | tetrahydropyridoimidazole-type | 1 |
| 296 | therapeutic-preventive | 1 |
| 297 | thermocol | 1 |
| 298 | thermopar | 1 |
| 299 | thirty-minute | 8 |
| 300 | time-place | 1 |
| 301 | tippee | 1 |
| 302 | tissue-wiping | 1 |
| 303 | tm-derived | 1 |
| 304 | treatments-three | 1 |
| 305 | triennial | 8 |
| 306 | tuesday-friday | 1 |
| 307 | typesof | 1 |
| 308 | udma-based | 1 |
| 309 | venepunctures | 4 |
| 310 | venous-line | 1 |
| 311 | voxel-level | 3 |
| 312 | was.43 | 1 |
| 313 | wasp-dependent | 3 |
| 314 | weeks-a | 1 |
| 315 | wire-top | 2 |
| 316 | xe-vacancy | 1 |
| 317 | μ2-phenoxo | 1 |
| 318 | ∼5-10 | 1 |
| 1 | ∼5-10 | 1 |
| 2 | +2030 | 1 |
| 3 | 15,930 | 1 |
| 4 | 589±640 | 1 |
| 5 | 26,670 | 1 |
| 6 | 1926±0 | 1 |
| 7 | mnaun+1 | 1 |
| 8 | 1123.1 | 1 |
| 9 | m=4721 | 1 |
| 10 | 51,791 | 1 |
| 11 | sets×8-12 | 1 |
| 12 | mean=1.12 | 1 |
| 13 | st12 | 1 |
| 14 | 15,332 | 1 |
| 15 | 19,282 | 1 |
| 16 | 9792 | 1 |
| 17 | ni13 | 1 |
| 18 | pt13 | 1 |
| 19 | +1033 | 1 |
| 20 | was.43 | 1 |
| 21 | denv3 | 2 |
| 22 | 7,24 | 2 |
| 23 | 64,474 | 1 |
| 24 | cu4i4 | 3 |
| 25 | 4471+/-2315 | 1 |
| 26 | 51,525 | 1 |
| 27 | 631-775 | 1 |
| 28 | 1∼5 | 1 |
| 29 | 2117.6 | 1 |
| 30 | +2456 | 1 |
| 31 | 640-756 | 1 |
| 32 | cirs-066 | 1 |
| 33 | fe-x6 | 1 |
| 34 | patients/7 | 2 |
| 35 | 616,607 | 1 |
| 36 | 398,237 | 1 |
| 37 | -637 | 1 |
| 38 | 1905±37 | 1 |
| 39 | 131,747 | 1 |
| 40 | almnau7 | 1 |
| 41 | 7×7 | 1 |
| 42 | 2,338 | 1 |
| 43 | mg8 | 1 |
| 44 | -6±109 | 1 |
| 45 | 13,089 | 1 |
| 46 | weeks-a | 1 |
| 47 | stent-era | 2 |
| 48 | mid-urethra | 1 |
| 49 | 28-kb | 1 |
| 50 | as-aerobic | 1 |
| 51 | sovrapubic | 2 |
| 52 | intrasaccadic | 1 |
| 53 | homogeneic | 1 |
| 54 | surface-specific | 3 |
| 55 | temperature-interval-specific | 1 |
| 56 | season-specific | 11 |
| 57 | lip-specific | 1 |
| 58 | pseudoischemic | 1 |
| 59 | iso-echoic | 1 |
| 60 | fibrin/semisynthetic | 1 |
| 61 | cytodiagnostic | 2 |
| 62 | 18-d | 1 |
| 63 | micro-ecd | 1 |
| 64 | guidewire-induced | 1 |
| 65 | solid-sided | 1 |
| 66 | pedometer-recorded | 2 |
| 67 | straw-enriched | 1 |
| 68 | previously-published | 5 |
| 69 | pre-pecified | 1 |
| 70 | stimulus-locked | 3 |
| 71 | ehr-enabled | 3 |
| 72 | climatic-controlled | 2 |
| 73 | temperature-controlled | 64 |
| 74 | climate-controlled | 17 |
| 75 | algorithm-defined | 2 |
| 76 | empirically-defined | 1 |
| 77 | convex-shaped | 1 |
| 78 | o-capped | 1 |
| 79 | even-numbered | 10 |
| 80 | non-triggered | 2 |
| 81 | nonindustry-sponsored | 1 |
| 82 | ruptured/unruptured | 2 |
| 83 | grpaca-based | 1 |
| 84 | udma-based | 1 |
| 85 | lignocellulosic-based | 1 |
| 86 | kaolinite-based | 1 |
| 87 | consumer-based | 4 |
| 88 | teacher-supervised | 2 |
| 89 | 1,10-phenanthroline-chelated | 1 |
| 90 | fungal-inoculated | 2 |
| 91 | levitated | 2 |
| 92 | sirt3-targeted | 1 |
| 93 | opposite-oriented | 1 |
| 94 | dna-supported | 1 |
| 95 | tm-derived | 1 |
| 96 | nonvisualized | 8 |
| 97 | moderate-sized | 22 |
| 98 | equal-sized | 22 |
| 99 | larger-sized | 6 |
| 100 | coxib-nsaid | 1 |
| 101 | nonsuspend | 2 |
| 102 | multirebound | 1 |
| 103 | time-place | 1 |
| 104 | 6-ounce | 1 |
| 105 | flexiforce | 1 |
| 106 | multi-diode | 2 |
| 107 | multidiode | 2 |
| 108 | tippee | 1 |
| 109 | rescue-free | 30 |
| 110 | albuterol-free | 1 |
| 111 | mutation-free | 3 |
| 112 | 90-degree | 10 |
| 113 | treatments-three | 1 |
| 114 | growsafe | 5 |
| 115 | levels-the | 1 |
| 116 | patients.the | 7 |
| 117 | production-scale | 5 |
| 118 | smaller-scale | 1 |
| 119 | clinically-interpretable | 1 |
| 120 | cluster-hole | 2 |
| 121 | intervention/outcome | 2 |
| 122 | purine-pyrimidine | 1 |
| 123 | venous-line | 1 |
| 124 | cis-fluorine | 1 |
| 125 | nrtis+one | 2 |
| 126 | tetrahydropyridoimidazole-type | 1 |
| 127 | film-type | 1 |
| 128 | extreme-high-temperature | 1 |
| 129 | quick-response | 1 |
| 130 | fast-response | 6 |
| 131 | gel-use | 2 |
| 132 | screenhouse | 1 |
| 133 | separate | 4,411 |
| 134 | thirty-minute | 8 |
| 135 | four-wave | 7 |
| 136 | successive | 873 |
| 137 | positive-to-negative | 4 |
| 138 | near-native | 1 |
| 139 | 3-dimension-perspective | 1 |
| 140 | therapeutic-preventive | 1 |
| 141 | festive | 2 |
| 142 | real-size | 2 |
| 143 | soundproof | 4 |
| 144 | typesof | 1 |
| 145 | 300-g | 2 |
| 146 | 0.2-g | 1 |
| 147 | 125-g | 1 |
| 148 | imp-15-producing | 1 |
| 149 | pcna-binding | 1 |
| 150 | phosphoserine/phosphothreonine-binding | 1 |
| 151 | nck-binding | 2 |
| 152 | slice-encoding | 2 |
| 153 | post-needling | 3 |
| 154 | pool-boiling | 1 |
| 155 | nonfilling | 1 |
| 156 | high-enrolling | 2 |
| 157 | poorly-performing | 1 |
| 158 | intron-containing | 6 |
| 159 | predictive-learning | 1 |
| 160 | tissue-wiping | 1 |
| 161 | face-sharing | 2 |
| 162 | saliva-sparing | 1 |
| 163 | nonheating | 2 |
| 164 | stereodifferentiating | 1 |
| 165 | flavonoid-glycosylating | 1 |
| 166 | co2-fixing | 2 |
| 167 | par-frying | 1 |
| 168 | 10-mm-long | 7 |
| 169 | 36-hour-long | 1 |
| 170 | 13-h | 5 |
| 171 | conc2h | 1 |
| 172 | hours/each | 1 |
| 173 | 2-k | 1 |
| 174 | skin-check | 1 |
| 175 | 1-mm-thick | 8 |
| 176 | biobrick | 1 |
| 177 | meta-analyses/network | 1 |
| 178 | 15-l | 2 |
| 179 | 100-kcal | 4 |
| 180 | non-meal | 1 |
| 181 | triennial | 8 |
| 182 | end-submaximal | 3 |
| 183 | nmesintra-vaginal | 1 |
| 184 | co-investigational | 1 |
| 185 | contralateral-central | 2 |
| 186 | host/metal | 1 |
| 187 | 0.2-g/dl | 1 |
| 188 | months.multi-level | 1 |
| 189 | voxel-level | 3 |
| 190 | congruency-level | 2 |
| 191 | 3-ml | 28 |
| 192 | thermocol | 1 |
| 193 | long-haul | 2 |
| 194 | successeful | 1 |
| 195 | 80-m | 3 |
| 196 | 7.0-mm | 1 |
| 197 | 10-mm | 110 |
| 198 | 20/10-mm | 1 |
| 199 | 20-mm | 13 |
| 200 | 1-mm | 92 |
| 201 | 1.2-mm | 5 |
| 202 | 0.32-mm | 1 |
| 203 | 0.72-mm | 1 |
| 204 | 3-mm | 68 |
| 205 | 13-mm | 2 |
| 206 | 4-mm | 65 |
| 207 | 1.4-mm | 1 |
| 208 | -12.4-mm | 1 |
| 209 | 4.4-mm | 1 |
| 210 | 24-mm | 3 |
| 211 | 5-mm | 145 |
| 212 | 25-mm | 9 |
| 213 | 0.6-mm | 8 |
| 214 | 5.6-mm | 1 |
| 215 | 7-mm | 16 |
| 216 | 2.7-mm | 4 |
| 217 | 3.7-mm | 2 |
| 218 | 4.7-mm | 2 |
| 219 | -5.7-mm | 1 |
| 220 | 2.8-mm | 3 |
| 221 | 1.9-mm | 3 |
| 222 | 7.9-mm | 1 |
| 223 | 169-mm | 1 |
| 224 | 179-mm | 1 |
| 225 | 151/90mm | 1 |
| 226 | 10.1mm | 1 |
| 227 | 8.0±5.1mm | 1 |
| 228 | 79.52mm | 1 |
| 229 | -10.3mm | 1 |
| 230 | 123.73mm | 1 |
| 231 | -11.4mm | 1 |
| 232 | 137.4mm | 1 |
| 233 | 0.4+/-18.4mm | 1 |
| 234 | 9.6±3.6mm | 1 |
| 235 | 126.7mm | 1 |
| 236 | 5.6+/-17.7mm | 1 |
| 237 | 147/87mm | 1 |
| 238 | 146/88mm | 1 |
| 239 | 109mm | 1 |
| 240 | 159mm | 1 |
| 241 | 199mm | 1 |
| 242 | 13:14-atom | 1 |
| 243 | 5rm-10rm | 1 |
| 244 | biotansform | 1 |
| 245 | sections-an | 1 |
| 246 | post-screen | 1 |
| 247 | floor-pen | 3 |
| 248 | techniques.in | 1 |
| 249 | closed-chain | 1 |
| 250 | 130-min | 1 |
| 251 | 7.9-min | 1 |
| 252 | prenucleation | 1 |
| 253 | image-detection | 1 |
| 254 | foot-detection | 1 |
| 255 | 10-repetition | 3 |
| 256 | australian-grown | 1 |
| 257 | dsr/placebo | 1 |
| 258 | months.no | 3 |
| 259 | moderate.two | 1 |
| 260 | μ2-phenoxo | 1 |
| 261 | 45cm-drop | 1 |
| 262 | wire-top | 2 |
| 263 | structured-group | 1 |
| 264 | another.subgroup | 1 |
| 265 | body-similar | 1 |
| 266 | thermopar | 1 |
| 267 | alncr | 1 |
| 268 | multi-tracer | 2 |
| 269 | 200-meter | 2 |
| 270 | 18-floor | 1 |
| 271 | raised-floor | 1 |
| 272 | fewer-than-four | 5 |
| 273 | fe-s | 18 |
| 274 | c-qids | 1 |
| 275 | gorges | 3 |
| 276 | stranguries | 1 |
| 277 | venepunctures | 4 |
| 278 | device-observers | 2 |
| 279 | alliqots | 1 |
| 280 | postintravenous | 2 |
| 281 | stoloniferous | 1 |
| 282 | mix-effect | 1 |
| 283 | content-distinct | 1 |
| 284 | lrrct | 1 |
| 285 | regular-set | 1 |
| 286 | day-shift | 13 |
| 287 | relative-benefit | 1 |
| 288 | carbohydrate-salt | 1 |
| 289 | pre-cimt | 2 |
| 290 | mock-restaurant | 1 |
| 291 | non-equidistant | 2 |
| 292 | mbc-resistant | 3 |
| 293 | wasp-dependent | 3 |
| 294 | 30-patient | 2 |
| 295 | 50-patient | 7 |
| 296 | controlled-environment | 5 |
| 297 | one-hour-treatment | 1 |
| 298 | non-hot | 2 |
| 299 | best/worst | 3 |
| 300 | sanjiu | 5 |
| 301 | 1500x | 1 |
| 302 | single-sex | 8 |
| 303 | aaq+amx | 1 |
| 304 | shoebox | 1 |
| 305 | tuesday-friday | 1 |
| 306 | xe-vacancy | 1 |
| 307 | drug-dependency | 1 |
| 308 | lowest-frequency | 1 |
| 309 | art-strategy | 2 |
| 310 | phamarcology | 1 |
| 311 | non-rainy | 1 |
| 312 | granny | 1 |
| 313 | preoperatory | 7 |
| 314 | early-onset/comorbidity | 2 |
| 315 | intermediate-quality | 3 |
| 316 | risk/severity | 1 |
| 317 | 2,450-mhz | 4 |
| 318 | 1-oz | 1 |